Leica Biosystems PD-L1 BOND antibody

Wednesday, 05 December, 2018 | Supplied by: Leica Microsystems Pty Ltd


Leica Biosystems’ PD-L1 BOND antibody is designed for use on the company’s fully automated BOND IHC and ISH staining platform.

The PD-L1 (programmed death - ligand 1) antibody uses the MKP1A07310 (clone 73-10) expressed by Abcam on behalf of Merck KGaA, which owns all IP rights to this antibody. It joins the ALK (anaplastic lymphoma kinase) antibody as the latest addition to Novocastra’s growing lung menu of primary antibodies.

Leica Biosystems has optimised these two clones into a ready-to-use format for use on the BOND IHC and ISH staining platform. This allows labs to perform ALK and PD-L1 testing on the BOND system with rapid turnaround times, reliable staining and walk-away convenience.

Online: www.leica-microsystems.com
Phone: 1800 625 286
Related Products

Innovative Research Animal Biologicals

Innovative Research offers a comprehensive selection of biological products sourced from various...

EpigenTek EpiQuik CUT&RUN m6A RNA Enrichment (MeRIP) Kit

The kit is a complete set of optimised buffers and reagents designed to enrich an RNA fragment...

Cayman Chemical Off-Patent Drug Screening Library (96-Well)

Featuring a curated collection of FDA-approved compounds that are no longer covered under...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd